APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lesinurad

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Lesinurad Industry Growth and Trends Forecast to 2032

Report ID 17329865011 February 2026109 pages

Choose your research edition.

Industry ResearchLesinurad Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Lesinurad Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Lesinurad Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lesinurad Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Lesinurad Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Lesinurad market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Lesinurad is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Lesinurad is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lesinurad is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lesinurad include Ausun Pharmaceutical, Cayman Chemical, CHEMO, Clearsynth, Manus Aktteva Biopharma LLP, MSN Labs, Nifty Labs, Target Mol and UQUIFA, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Lesinurad market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lesinurad market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lesinurad market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lesinurad.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Lesinurad market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lesinurad Market by Company

Ausun Pharmaceutical

Cayman Chemical

CHEMO

Clearsynth

Manus Aktteva Biopharma LLP

MSN Labs

Nifty Labs

Target Mol

UQUIFA

Meso Chem

Vcare Pharmatech

Lesinurad Segment by Type

Purity ≥ 98 %

Purity ≥ 99 %

Lesinurad Segment by Application

Research Institute

Pharmaceutical

Others

Lesinurad Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lesinurad market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lesinurad and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lesinurad.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lesinurad manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Lesinurad in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity ≥ 98 % Table 2. Major Company of Purity ≥ 99 % Table 3. Global Lesinurad Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Lesinurad Sales by Type (2021-2026) & (t) Table 5. Global Lesinurad Sales Market Share in Volume by Type (2021-2026) Table 6. Global Lesinurad Sales by Type (2021-2026) & (US$ Million) Table 7. Global Lesinurad Sales Market Share in Value by Type (2021-2026) Table 8. Global Lesinurad Price by Type (2021-2026) & (USD/t) Table 9. Global Lesinurad Sales by Type (2027-2032) & (t) Table 10. Global Lesinurad Sales Market Share in Volume by Type (2027-2032) Table 11. Global Lesinurad Sales by Type (2027-2032) & (US$ Million) Table 12. Global Lesinurad Sales Market Share in Value by Type (2027-2032) Table 13. Global Lesinurad Price by Type (2027-2032) & (USD/t) Table 14. North America Lesinurad Sales by Type (2021-2026) & (t) Table 15. North America Lesinurad Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Lesinurad Sales by Type (2021-2026) & (t) Table 17. Europe Lesinurad Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Lesinurad Sales by Type (2021-2026) & (t) Table 19. Asia-Pacific Lesinurad Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Lesinurad Sales by Type (2021-2026) & (t) Table 21. Latin America Lesinurad Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Lesinurad Sales by Type (2021-2026) & (t) Table 23. Middle East and Africa Lesinurad Sales by Type (2021-2026) & (US$ Million) Table 24. Lesinurad Industry Trends Table 25. Lesinurad Industry Drivers Table 26. Lesinurad Industry Opportunities and Challenges Table 27. Lesinurad Industry Restraints Table 28. Global Lesinurad Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Lesinurad Revenue Market Share by Company (2021-2026) Table 30. Global Lesinurad Sales by Company (2021-2026) & (t) Table 31. Global Lesinurad Sales Share by Company (2021-2026) Table 32. Global Lesinurad Market Price by Company (2021-2026) & (USD/t) Table 33. Global Lesinurad Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Lesinurad Major Company Production Sites and Headquarters Table 35. Global Lesinurad Company, Product Type & Application Table 36. Global Lesinurad Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Lesinurad by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Lesinurad Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Lesinurad Sales by Region (2021-2026) & (t) Table 41. Global Lesinurad Sales Market Share in Volume by Region (2021-2026) Table 42. Global Lesinurad Sales by Region (2021-2026) & (US$ Million) Table 43. Global Lesinurad Sales Market Share in Value by Region (2021-2026) Table 44. Global Lesinurad Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 45. Global Lesinurad Sales by Region (2027-2032) & (t) Table 46. Global Lesinurad Sales Market Share in Volume by Region (2027-2032) Table 47. Global Lesinurad Sales by Region (2027-2032) & (US$ Million) Table 48. Global Lesinurad Sales Market Share in Value by Region (2027-2032) Table 49. Global Lesinurad Sales (t), Value (US$ Million), Price (USD/t) and Gross Margin (2027-2032) Table 50. Global Lesinurad Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Lesinurad Sales by Application (2021-2026) & (t) Table 52. Global Lesinurad Sales Market Share in Volume by Application (2021-2026) Table 53. Global Lesinurad Sales by Application (2021-2026) & (US$ Million) Table 54. Global Lesinurad Sales Market Share in Value by Application (2021-2026) Table 55. Global Lesinurad Price by Application (2021-2026) & (USD/t) Table 56. Global Lesinurad Sales by Application (2027-2032) & (t) Table 57. Global Lesinurad Sales Market Share in Volume by Application (2027-2032) Table 58. Global Lesinurad Sales by Application (2027-2032) & (US$ Million) Table 59. Global Lesinurad Sales Market Share in Value by Application (2027-2032) Table 60. Global Lesinurad Price by Application (2027-2032) & (USD/t) Table 61. North America Lesinurad Sales by Application (2021-2026) & (t) Table 62. North America Lesinurad Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Lesinurad Sales by Application (2021-2026) & (t) Table 64. Europe Lesinurad Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Lesinurad Sales by Application (2021-2026) & (t) Table 66. Asia-Pacific Lesinurad Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Lesinurad Sales by Application (2021-2026) & (t) Table 68. Latin America Lesinurad Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Lesinurad Sales by Application (2021-2026) & (t) Table 70. Middle East and Africa Lesinurad Sales by Application (2021-2026) & (US$ Million) Table 71. Ausun Pharmaceutical Company Information Table 72. Ausun Pharmaceutical Business Overview Table 73. Ausun Pharmaceutical Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. Ausun Pharmaceutical Lesinurad Product Portfolio Table 75. Ausun Pharmaceutical Recent Development Table 76. Cayman Chemical Company Information Table 77. Cayman Chemical Business Overview Table 78. Cayman Chemical Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. Cayman Chemical Lesinurad Product Portfolio Table 80. Cayman Chemical Recent Development Table 81. CHEMO Company Information Table 82. CHEMO Business Overview Table 83. CHEMO Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. CHEMO Lesinurad Product Portfolio Table 85. CHEMO Recent Development Table 86. Clearsynth Company Information Table 87. Clearsynth Business Overview Table 88. Clearsynth Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. Clearsynth Lesinurad Product Portfolio Table 90. Clearsynth Recent Development Table 91. Manus Aktteva Biopharma LLP Company Information Table 92. Manus Aktteva Biopharma LLP Business Overview Table 93. Manus Aktteva Biopharma LLP Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. Manus Aktteva Biopharma LLP Lesinurad Product Portfolio Table 95. Manus Aktteva Biopharma LLP Recent Development Table 96. MSN Labs Company Information Table 97. MSN Labs Business Overview Table 98. MSN Labs Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 99. MSN Labs Lesinurad Product Portfolio Table 100. MSN Labs Recent Development Table 101. Nifty Labs Company Information Table 102. Nifty Labs Business Overview Table 103. Nifty Labs Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 104. Nifty Labs Lesinurad Product Portfolio Table 105. Nifty Labs Recent Development Table 106. Target Mol Company Information Table 107. Target Mol Business Overview Table 108. Target Mol Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 109. Target Mol Lesinurad Product Portfolio Table 110. Target Mol Recent Development Table 111. UQUIFA Company Information Table 112. UQUIFA Business Overview Table 113. UQUIFA Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 114. UQUIFA Lesinurad Product Portfolio Table 115. UQUIFA Recent Development Table 116. Meso Chem Company Information Table 117. Meso Chem Business Overview Table 118. Meso Chem Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 119. Meso Chem Lesinurad Product Portfolio Table 120. Meso Chem Recent Development Table 121. Vcare Pharmatech Company Information Table 122. Vcare Pharmatech Business Overview Table 123. Vcare Pharmatech Lesinurad Sales (t), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 124. Vcare Pharmatech Lesinurad Product Portfolio Table 125. Vcare Pharmatech Recent Development Table 126. North America Lesinurad Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 127. North America Lesinurad Sales by Country (2021-2026) & (t) Table 128. North America Lesinurad Sales Market Share by Country (2021-2026) Table 129. North America Lesinurad Sales Forecast by Country (2027-2032) & (t) Table 130. North America Lesinurad Sales Market Share Forecast by Country (2027-2032) Table 131. North America Lesinurad Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Lesinurad Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Lesinurad Market Share by Country (2021-2026) Table 134. North America Lesinurad Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Lesinurad Market Share Forecast by Country (2027-2032) Table 136. Europe Lesinurad Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 137. Europe Lesinurad Sales by Country (2021-2026) & (t) Table 138. Europe Lesinurad Sales Market Share by Country (2021-2026) Table 139. Europe Lesinurad Sales Forecast by Country (2027-2032) & (t) Table 140. Europe Lesinurad Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Lesinurad Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Lesinurad Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Lesinurad Market Share by Country (2021-2026) Table 144. Europe Lesinurad Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Lesinurad Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Lesinurad Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Lesinurad Sales by Country (2021-2026) & (t) Table 148. Asia-Pacific Lesinurad Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Lesinurad Sales Forecast by Country (2027-2032) & (t) Table 150. Asia-Pacific Lesinurad Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Lesinurad Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Lesinurad Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Lesinurad Market Share by Country (2021-2026) Table 154. Asia-Pacific Lesinurad Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Lesinurad Market Share Forecast by Country (2027-2032) Table 156. Latin America Lesinurad Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 157. Latin America Lesinurad Sales by Country (2021-2026) & (t) Table 158. Latin America Lesinurad Sales Market Share by Country (2021-2026) Table 159. Latin America Lesinurad Sales Forecast by Country (2027-2032) & (t) Table 160. Latin America Lesinurad Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Lesinurad Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Lesinurad Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Lesinurad Market Share by Country (2021-2026) Table 164. Latin America Lesinurad Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Lesinurad Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Lesinurad Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Lesinurad Sales by Country (2021-2026) & (t) Table 168. Middle East and Africa Lesinurad Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Lesinurad Sales Forecast by Country (2027-2032) & (t) Table 170. Middle East and Africa Lesinurad Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Lesinurad Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Lesinurad Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Lesinurad Market Share by Country (2021-2026) Table 174. Middle East and Africa Lesinurad Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Lesinurad Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Lesinurad Distributors List Table 179. Lesinurad Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Lesinurad Image Figure 2. Global Lesinurad Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lesinurad Market Size (2021-2032) & (US$ Million) Figure 4. Global Lesinurad Sales (2021-2032) & (t) Figure 5. Purity ≥ 98 % Image Figure 6. Global Purity ≥ 98 % Sales YoY Growth (2021-2032) & (t) Figure 7. Purity ≥ 99 % Image Figure 8. Global Purity ≥ 99 % Sales YoY Growth (2021-2032) & (t) Figure 9. Global Lesinurad Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Lesinurad Market Share by Type 2025 VS 2032 Figure 11. North America Lesinurad Sales Market Share in Volume by Type in 2025 Figure 12. North America Lesinurad Sales Market Share in Value by Type in 2025 Figure 13. Europe Lesinurad Sales Market Share in Volume by Type in 2025 Figure 14. Europe Lesinurad Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Lesinurad Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Lesinurad Sales Market Share in Value by Type in 2025 Figure 17. Latin America Lesinurad Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Lesinurad Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Lesinurad Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Lesinurad Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Lesinurad Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Research Institute Image Figure 24. Global Research Institute Sales YoY Growth (2021-2032) & (t) Figure 25. Pharmaceutical Image Figure 26. Global Pharmaceutical Sales YoY Growth (2021-2032) & (t) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (t) Figure 29. Global Lesinurad Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Lesinurad Market Share by Application 2025 VS 2032 Figure 31. North America Lesinurad Sales Market Share in Volume by Application in 2025 Figure 32. North America Lesinurad Sales Market Share in Value by Application in 2025 Figure 33. Europe Lesinurad Sales Market Share in Volume by Application in 2025 Figure 34. Europe Lesinurad Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Lesinurad Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Lesinurad Sales Market Share in Value by Application in 2025 Figure 37. Latin America Lesinurad Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Lesinurad Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Lesinurad Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Lesinurad Sales Market Share in Value by Application in 2025 Figure 41. North America Lesinurad Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 42. North America Lesinurad Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Lesinurad Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Lesinurad Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Lesinurad Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 46. Europe Lesinurad Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Lesinurad Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Lesinurad Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Lesinurad Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 50. Asia-Pacific Lesinurad Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Lesinurad Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Lesinurad Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Lesinurad Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 54. Latin America Lesinurad Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Lesinurad Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Lesinurad Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Lesinurad Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 58. Middle East and Africa Lesinurad Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Lesinurad Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Lesinurad Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Lesinurad Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Lesinurad Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥ 98 %
  • Purity ≥ 99 %
Applications
  • Research Institute
  • Pharmaceutical
  • Others
Companies covered
  • Ausun Pharmaceutical
  • Cayman Chemical
  • CHEMO
  • Clearsynth
  • Manus Aktteva Biopharma LLP
  • MSN Labs
  • Nifty Labs
  • Target Mol
  • UQUIFA
  • Meso Chem
  • Vcare Pharmatech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lesinurad Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Lesinurad Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Lesinurad Market by Type
  6. 1.3.1 Purity ≥ 98 %
  7. 1.3.2 Purity ≥ 99 %
  8. 1.4 Global Lesinurad Market Size by Type
  9. 1.4.1 Global Lesinurad Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Lesinurad Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Lesinurad Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Lesinurad Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Lesinurad Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Lesinurad Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Lesinurad Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Lesinurad Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Lesinurad Industry Trends
  2. 2.2 Lesinurad Industry Drivers
  3. 2.3 Lesinurad Industry Opportunities and Challenges
  4. 2.4 Lesinurad Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Lesinurad Revenue (2021-2026)
  2. 3.2 Global Top Players by Lesinurad Sales (2021-2026)
  3. 3.3 Global Top Players by Lesinurad Price (2021-2026)
  4. 3.4 Global Lesinurad Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lesinurad Major Company Production Sites & Headquarters
  6. 3.6 Global Lesinurad Company, Product Type & Application
  7. 3.7 Global Lesinurad Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lesinurad Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lesinurad Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lesinurad Tier 1, Tier 2, and Tier 3
4 Lesinurad Regional Status and Outlook
  1. 4.1 Global Lesinurad Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Lesinurad Historic Market Size by Region
  3. 4.2.1 Global Lesinurad Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Lesinurad Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Lesinurad Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Lesinurad Forecasted Market Size by Region
  7. 4.3.1 Global Lesinurad Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Lesinurad Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Lesinurad Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Lesinurad by Application
  1. 5.1 Lesinurad Market by Application
  2. 5.1.1 Research Institute
  3. 5.1.2 Pharmaceutical
  4. 5.1.3 Others
  5. 5.2 Global Lesinurad Market Size by Application
  6. 5.2.1 Global Lesinurad Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Lesinurad Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Lesinurad Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Lesinurad Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Lesinurad Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Lesinurad Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Lesinurad Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Lesinurad Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Ausun Pharmaceutical
  2. 6.1.1 Ausun Pharmaceutical Company Information
  3. 6.1.2 Ausun Pharmaceutical Business Overview
  4. 6.1.3 Ausun Pharmaceutical Lesinurad Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Ausun Pharmaceutical Lesinurad Product Portfolio
  6. 6.1.5 Ausun Pharmaceutical Recent Developments
  7. 6.2 Cayman Chemical
  8. 6.2.1 Cayman Chemical Company Information
  9. 6.2.2 Cayman Chemical Business Overview
  10. 6.2.3 Cayman Chemical Lesinurad Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cayman Chemical Lesinurad Product Portfolio
  12. 6.2.5 Cayman Chemical Recent Developments
  13. 6.3 CHEMO
  14. 6.3.1 CHEMO Company Information
  15. 6.3.2 CHEMO Business Overview
  16. 6.3.3 CHEMO Lesinurad Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CHEMO Lesinurad Product Portfolio
  18. 6.3.5 CHEMO Recent Developments
  19. 6.4 Clearsynth
  20. 6.4.1 Clearsynth Company Information
  21. 6.4.2 Clearsynth Business Overview
  22. 6.4.3 Clearsynth Lesinurad Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Clearsynth Lesinurad Product Portfolio
  24. 6.4.5 Clearsynth Recent Developments
  25. 6.5 Manus Aktteva Biopharma LLP
  26. 6.5.1 Manus Aktteva Biopharma LLP Company Information
  27. 6.5.2 Manus Aktteva Biopharma LLP Business Overview
  28. 6.5.3 Manus Aktteva Biopharma LLP Lesinurad Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Manus Aktteva Biopharma LLP Lesinurad Product Portfolio
  30. 6.5.5 Manus Aktteva Biopharma LLP Recent Developments
  31. 6.6 MSN Labs
  32. 6.6.1 MSN Labs Company Information
  33. 6.6.2 MSN Labs Business Overview
  34. 6.6.3 MSN Labs Lesinurad Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 MSN Labs Lesinurad Product Portfolio
  36. 6.6.5 MSN Labs Recent Developments
  37. 6.7 Nifty Labs
  38. 6.7.1 Nifty Labs Company Information
  39. 6.7.2 Nifty Labs Business Overview
  40. 6.7.3 Nifty Labs Lesinurad Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Nifty Labs Lesinurad Product Portfolio
  42. 6.7.5 Nifty Labs Recent Developments
  43. 6.8 Target Mol
  44. 6.8.1 Target Mol Company Information
  45. 6.8.2 Target Mol Business Overview
  46. 6.8.3 Target Mol Lesinurad Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Target Mol Lesinurad Product Portfolio
  48. 6.8.5 Target Mol Recent Developments
  49. 6.9 UQUIFA
  50. 6.9.1 UQUIFA Company Information
  51. 6.9.2 UQUIFA Business Overview
  52. 6.9.3 UQUIFA Lesinurad Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 UQUIFA Lesinurad Product Portfolio
  54. 6.9.5 UQUIFA Recent Developments
  55. 6.10 Meso Chem
  56. 6.10.1 Meso Chem Company Information
  57. 6.10.2 Meso Chem Business Overview
  58. 6.10.3 Meso Chem Lesinurad Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Meso Chem Lesinurad Product Portfolio
  60. 6.10.5 Meso Chem Recent Developments
  61. 6.11 Vcare Pharmatech
  62. 6.11.1 Vcare Pharmatech Company Information
  63. 6.11.2 Vcare Pharmatech Business Overview
  64. 6.11.3 Vcare Pharmatech Lesinurad Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Vcare Pharmatech Lesinurad Product Portfolio
  66. 6.11.5 Vcare Pharmatech Recent Developments
7 North America by Country
  1. 7.1 North America Lesinurad Sales by Country
  2. 7.1.1 North America Lesinurad Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Lesinurad Sales by Country (2021-2026)
  4. 7.1.3 North America Lesinurad Sales Forecast by Country (2027-2032)
  5. 7.2 North America Lesinurad Market Size by Country
  6. 7.2.1 North America Lesinurad Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Lesinurad Market Size by Country (2021-2026)
  8. 7.2.3 North America Lesinurad Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Lesinurad Sales by Country
  2. 8.1.1 Europe Lesinurad Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Lesinurad Sales by Country (2021-2026)
  4. 8.1.3 Europe Lesinurad Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Lesinurad Market Size by Country
  6. 8.2.1 Europe Lesinurad Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Lesinurad Market Size by Country (2021-2026)
  8. 8.2.3 Europe Lesinurad Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Lesinurad Sales by Country
  2. 9.1.1 Asia-Pacific Lesinurad Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Lesinurad Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Lesinurad Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Lesinurad Market Size by Country
  6. 9.2.1 Asia-Pacific Lesinurad Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Lesinurad Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Lesinurad Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Lesinurad Sales by Country
  2. 10.1.1 South America Lesinurad Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Lesinurad Sales by Country (2021-2026)
  4. 10.1.3 South America Lesinurad Sales Forecast by Country (2027-2032)
  5. 10.2 South America Lesinurad Market Size by Country
  6. 10.2.1 South America Lesinurad Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Lesinurad Market Size by Country (2021-2026)
  8. 10.2.3 South America Lesinurad Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Lesinurad Sales by Country
  2. 11.1.1 Middle East and Africa Lesinurad Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Lesinurad Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Lesinurad Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Lesinurad Market Size by Country
  6. 11.2.1 Middle East and Africa Lesinurad Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Lesinurad Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Lesinurad Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Lesinurad Value Chain Analysis
  2. 12.1.1 Lesinurad Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Lesinurad Production Mode & Process
  7. 12.2 Lesinurad Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Lesinurad Distributors
  10. 12.2.3 Lesinurad Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst